{"entity":{"type":"insider","cik":"0001726533","url":"/insider/0001726533","json_url":"/insider/0001726533.json","name":"O'Grady Brendan P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":16,"first":"2018-03-06","last":"2024-11-15","span_basis":"filed_date"},"name_variants":[{"name":"O'Grady Brendan P.","source":"filing","n_filings":16,"first_seen":"2018-03-06","last_seen":"2024-11-15"}],"transactions":[{"id":2472257,"accession":"0001104659-24-119663","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-119663","line_url":"/filing/0001104659-24-119663#line-1","is_derivative":false,"issuer_cik":"0001726533","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001726533","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11706.462,"shares_display":"11,706.46","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":9950.4927,"total_display":"9,950.49","total_whole":"9,950","shares_owned_after":11706.462,"shares_owned_after_display":"11,706.46","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-14","filed_date":"2024-11-15","scope":"insider"},{"id":4138490,"accession":"0001209191-21-018526","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-018526","line_url":"/filing/0001209191-21-018526#line-4","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11436.0,"shares_display":"11,436","price_per_share":10.5439,"price_display":"10.54","price_state":"stated","total_value":120580.0404,"total_display":"120,580.04","total_whole":"120,580","shares_owned_after":14868.486,"shares_owned_after_display":"14,868.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":4138488,"accession":"0001209191-21-018526","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-018526","line_url":"/filing/0001209191-21-018526","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8172.0,"shares_display":"8,172","price_per_share":10.58622135340186,"price_display":"10.59","price_state":"stated","total_value":86510.6009,"total_display":"86,510.60","total_whole":"86,511","shares_owned_after":26304.486,"shares_owned_after_display":"26,304.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-08","scope":"insider","n_lines":2},{"id":5245023,"accession":"0001209191-21-017764","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-017764","line_url":"/filing/0001209191-21-017764#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":463.0,"shares_display":"463","price_per_share":10.8626,"price_display":"10.86","price_state":"stated","total_value":5029.3838,"total_display":"5,029.38","total_whole":"5,029","shares_owned_after":15571.486,"shares_owned_after_display":"15,571.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-04","scope":"insider"},{"id":5245016,"accession":"0001209191-21-017764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017764","line_url":"/filing/0001209191-21-017764#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15085.0,"shares_display":"15,085","price_per_share":10.8453,"price_display":"10.85","price_state":"stated","total_value":163601.3505,"total_display":"163,601.35","total_whole":"163,601","shares_owned_after":14868.486,"shares_owned_after_display":"14,868.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider"},{"id":5322293,"accession":"0001209191-21-015852","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-015852","line_url":"/filing/0001209191-21-015852","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73127.0,"shares_display":"73,127","price_per_share":10.912832004594746,"price_display":"10.91","price_state":"stated","total_value":798022.666,"total_display":"798,022.67","total_whole":"798,023","shares_owned_after":29953.486,"shares_owned_after_display":"29,953.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider","n_lines":2},{"id":5144886,"accession":"0001209191-21-009639","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009639","line_url":"/filing/0001209191-21-009639","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20694.0,"shares_display":"20,694","price_per_share":12.6945,"price_display":"12.69","price_state":"stated","total_value":262699.983,"total_display":"262,699.98","total_whole":"262,700","shares_owned_after":78146.486,"shares_owned_after_display":"78,146.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider","n_lines":2},{"id":2878576,"accession":"0001209191-20-020165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020165","line_url":"/filing/0001209191-20-020165#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":470.0,"shares_display":"470","price_per_share":7.1635,"price_display":"7.16","price_state":"stated","total_value":3366.845,"total_display":"3,366.84","total_whole":"3,367","shares_owned_after":14868.486,"shares_owned_after_display":"14,868.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":2109238,"accession":"0001209191-20-016461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016461","line_url":"/filing/0001209191-20-016461#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":463.0,"shares_display":"463","price_per_share":11.3658,"price_display":"11.37","price_state":"stated","total_value":5262.3654,"total_display":"5,262.37","total_whole":"5,262","shares_owned_after":14159.486,"shares_owned_after_display":"14,159.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"},{"id":3188298,"accession":"0001209191-20-008166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-008166","line_url":"/filing/0001209191-20-008166#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4799.0,"shares_display":"4,799","price_per_share":12.27,"price_display":"12.27","price_state":"stated","total_value":58883.73,"total_display":"58,883.73","total_whole":"58,884","shares_owned_after":13456.486,"shares_owned_after_display":"13,456.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-11","scope":"insider"},{"id":8396263,"accession":"0001209191-19-050266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-050266","line_url":"/filing/0001209191-19-050266#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":494.0,"shares_display":"494","price_per_share":7.8313,"price_display":"7.83","price_state":"stated","total_value":3868.6622,"total_display":"3,868.66","total_whole":"3,869","shares_owned_after":2135.486,"shares_owned_after_display":"2,135.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":7867993,"accession":"0001209191-19-020163","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020163","line_url":"/filing/0001209191-19-020163#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1179.0,"shares_display":"1,179","price_per_share":16.6251,"price_display":"16.63","price_state":"stated","total_value":19600.9929,"total_display":"19,600.99","total_whole":"19,601","shares_owned_after":1388.486,"shares_owned_after_display":"1,388.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":7788491,"accession":"0001209191-19-019332","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019332","line_url":"/filing/0001209191-19-019332#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":738.0,"shares_display":"738","price_per_share":15.6749,"price_display":"15.67","price_state":"stated","total_value":11568.0762,"total_display":"11,568.08","total_whole":"11,568","shares_owned_after":1388.486,"shares_owned_after_display":"1,388.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":8389911,"accession":"0001209191-19-016093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-016093","line_url":"/filing/0001209191-19-016093#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1166.0,"shares_display":"1,166","price_per_share":16.8833,"price_display":"16.88","price_state":"stated","total_value":19685.9278,"total_display":"19,685.93","total_whole":"19,686","shares_owned_after":1388.486,"shares_owned_after_display":"1,388.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-05","scope":"insider"},{"id":6913223,"accession":"0001209191-18-051780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-051780","line_url":"/filing/0001209191-18-051780#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":23.707,"price_display":"23.71","price_state":"stated","total_value":29420.387,"total_display":"29,420.39","total_whole":"29,420","shares_owned_after":1388.486,"shares_owned_after_display":"1,388.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":6015973,"accession":"0001209191-18-020864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020864","line_url":"/filing/0001209191-18-020864#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1179.0,"shares_display":"1,179","price_per_share":17.878,"price_display":"17.88","price_state":"stated","total_value":21078.162,"total_display":"21,078.16","total_whole":"21,078","shares_owned_after":1388.486,"shares_owned_after_display":"1,388.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-20","scope":"insider"},{"id":6658611,"accession":"0001209191-18-019567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-019567","line_url":"/filing/0001209191-18-019567#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":738.0,"shares_display":"738","price_per_share":19.489,"price_display":"19.49","price_state":"stated","total_value":14382.882,"total_display":"14,382.88","total_whole":"14,383","shares_owned_after":1388.486,"shares_owned_after_display":"1,388.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"},{"id":6234136,"accession":"0001209191-18-017230","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-017230","line_url":"/filing/0001209191-18-017230#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726533","owner_name":"O'Grady Brendan P.","owner_display_name":"O'Grady Brendan P.","owner_url":"/insider/0001726533","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":705.0,"shares_display":"705","price_per_share":19.38,"price_display":"19.38","price_state":"stated","total_value":13662.9,"total_display":"13,662.90","total_whole":"13,663","shares_owned_after":1388.486,"shares_owned_after_display":"1,388.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001808665","name":"Assertio Holdings, Inc.","url":"/issuer/0001808665","role":"Director, Officer (CEO)","n_filings":1,"first_seen":"2024-11-15","last_seen":"2024-11-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (EVP, North America Commercial)","n_filings":15,"first_seen":"2018-03-06","last_seen":"2021-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001726533","retrieved_at":"2026-08-24T17:44:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}